COTY reports today, and a sharp shift in options positioning overnight is the most notable change from the pre-earnings setup described in yesterday's preview.
The put/call ratio jumped to 0.36 on August 19 — more than four standard deviations above its 20-day average of 0.30, and the highest defensive reading in months. That is a dramatic single-session move given how consistently call-skewed the options market had been heading into the print. For weeks the PCR had hugged the low 0.29-0.30 range; the sudden rotation toward puts on the day of the event suggests some investors moved to hedge positions into the number. The stock itself has rallied sharply, up 10.6% on the day and 16% over the past month to $3.03, which makes the defensive tilt in options more notable — protection becomes cheaper to ignore when a stock has run, yet traders paid for it anyway.
Short interest tells a stable, benign story by comparison. As noted in yesterday's post-earnings note, the covering trend that defined July has now paused. Short interest is running at 5.24% of free float — down from nearly 7.1% in early July but no longer falling. The borrow market remains entirely loose: availability is 365% of short interest, meaning roughly 249 million shares are still available to lend against a 45.8 million-share short position, and cost to borrow is just 0.43%. There is no squeeze pressure here.
The fundamental debate remains divided. The analyst consensus is a hold, with most recent target moves — from Citigroup and TD Cowen after the prior quarter — landing in the $2.80-$2.90 range, well below the current price. RBC Capital is the notable outlier, holding an Outperform with an $8 target, though that reading is from May and now looks particularly detached from where the stock trades. Bears point to ongoing weakness in fragrance and consumer cosmetics, competition from social-media-driven brands, and China execution risk. Bulls lean on new leadership, a strategic reset, and a valuation that remains cheap on book and earnings metrics — the price-to-book is below 0.71 and EV/EBITDA sits around 8.2x. The stock's 90-day EPS surprise factor ranks in the 100th percentile, meaning it has beaten expectations more consistently than almost any peer in the universe.
History adds a note of caution. The last two prints delivered immediate one-day declines of 6.8% and 2.3%, with five-day drawdowns of 17.6% and 14.1% respectively — a consistently punishing pattern after results day, regardless of how positioning was set beforehand. Today's print will test whether the stock's sharp pre-earnings rally has already priced in a better outcome, or whether the defensive options activity that emerged on August 19 was correctly anticipating a familiar post-results fade.
See the live data behind this article on ORTEX.
Open COTY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
